Our results suggest that doxycycline has an inhibiting effect on LPS priming of the inflammasome, and that it can attenuate the production of pro-CASP1 and NLRP3 RNA and NLRP3 protein assembly irrespective of the level of IL-1β production and secretion in these tumor cells. The gene discussed is IL1B; the disease is neoplasm.